Prospective observational study evaluates long-term outcomes of induction chemoradiotherapy followed by surgery for NSCLC, suggesting alternative treatment options.
Purpose: Although immune checkpoint inhibitor-based perioperative therapy has become the standard for resectable stage IIIA-N2 non-small cell lung cancer (NSCLC), not all patients are eligible for this approach. This study evaluated long-term outcomes of histology-based induction chemoradiotherapy (CRT) followed by surgery.
No takes yet. Share an insight, caveat, or question.
Ishibashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: